These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38740191)
1. Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2. Huang J; Wang W; Li H; Bai Y; Song Y; Jiao C; Jin H; Huang P; Zhang H; Xia X; Yan F; Li Y; Wang H Antiviral Res; 2024 Jul; 227():105905. PubMed ID: 38740191 [TBL] [Abstract][Full Text] [Related]
2. Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge. Wang G; Verma AK; Guan X; Bu F; Odle AE; Li F; Liu B; Perlman S; Du L J Virol; 2024 Sep; 98(9):e0037624. PubMed ID: 39189731 [TBL] [Abstract][Full Text] [Related]
3. MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses. Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Corzo C; Noriega MA; Sánchez-Cordón PJ; Labiod N; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J Front Immunol; 2024; 15():1420304. PubMed ID: 39267752 [TBL] [Abstract][Full Text] [Related]
4. Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity. Ramírez MA; Loaiza RA; Martínez-Balboa Y; Bruneau N; Ramírez E; González PA; Bueno SM; Kalergis AM Vaccine; 2024 Oct; 42(23):126203. PubMed ID: 39178767 [TBL] [Abstract][Full Text] [Related]
5. Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice. Zhu J; Wang Z; Li Y; Zhang Z; Ren S; Wang J; Xie S; Liao Z; Song B; Wu W; Yan F; Peng C J Virol; 2024 Jul; 98(7):e0052124. PubMed ID: 38874361 [TBL] [Abstract][Full Text] [Related]
6. A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants. Hao T; Li Y; Liu P; Wang X; Xu K; Lei W; Li Y; Zhang R; Li X; Zhao X; Xu K; Lu X; Bi Y; Song H; Wu G; Zhu B; Gao GF PLoS Pathog; 2024 Sep; 20(9):e1012508. PubMed ID: 39303003 [TBL] [Abstract][Full Text] [Related]
7. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines. Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287 [TBL] [Abstract][Full Text] [Related]
8. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium. Marcos-Villar L; Perdiguero B; López-Bravo M; Zamora C; Sin L; Álvarez E; Sorzano CÓS; Sánchez-Cordón PJ; Casasnovas JM; Astorgano D; García-Arriaza J; Anthiya S; Borrajo ML; Lou G; Cuesta B; Franceschini L; Gelpí JL; Thielemans K; Sisteré-Oró M; Meyerhans A; García F; Esteban I; López-Bigas N; Plana M; Alonso MJ; Esteban M; Gómez CE Emerg Microbes Infect; 2024 Dec; 13(1):2387906. PubMed ID: 39087555 [TBL] [Abstract][Full Text] [Related]
9. An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV. Zhang H; Jin H; Yan F; Song Y; Dai J; Jiao C; Bai Y; Sun J; Liu D; Wang S; Zhang M; Lu J; Huang J; Huang P; Li Y; Xia X; Wang H Virol Sin; 2023 Apr; 38(2):244-256. PubMed ID: 36587795 [TBL] [Abstract][Full Text] [Related]
10. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants. Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM Elife; 2022 Aug; 11():. PubMed ID: 36004719 [TBL] [Abstract][Full Text] [Related]
11. A decavalent composite mRNA vaccine against both influenza and COVID-19. Wang Y; Ma Q; Li M; Mai Q; Ma L; Zhang H; Zhong H; Mai K; Cheng N; Feng P; Guan P; Wu S; Zhang L; Dai J; Zhang B; Pan W; Yang Z mBio; 2024 Sep; 15(9):e0066824. PubMed ID: 39105586 [TBL] [Abstract][Full Text] [Related]
12. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters. Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509 [TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses. Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222 [TBL] [Abstract][Full Text] [Related]
14. A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice. Wang Z; Sun W; Li D; Sun Y; Zhu M; Wang W; Zhang Y; Li E; Yan F; Wang T; Feng N; Yang S; Xia X; Gao Y Virus Res; 2024 Jul; 345():199378. PubMed ID: 38643857 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice. Li E; Yan F; Huang P; Chi H; Xu S; Li G; Liu C; Feng N; Wang H; Zhao Y; Yang S; Xia X Viruses; 2020 Jan; 12(1):. PubMed ID: 31968702 [TBL] [Abstract][Full Text] [Related]
16. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Xu K; An Y; Li Q; Huang W; Han Y; Zheng T; Fang F; Liu H; Liu C; Gao P; Xu S; Liu X; Zhang R; Zhao X; Liu WJ; Bi Y; Wang Y; Zhou D; Wang Q; Hou W; Xia Q; Gao GF; Dai L Emerg Microbes Infect; 2021 Dec; 10(1):1574-1588. PubMed ID: 34289779 [TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development. Jearanaiwitayakul T; Sunintaboon P; Kittiayuwat A; Limthongkul J; Wathanaphol J; Janhirun Y; Lerdsamran H; Wiriyarat W; Ubol S Vaccine; 2024 Jun; 42(17):3664-3673. PubMed ID: 38714446 [TBL] [Abstract][Full Text] [Related]
18. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike. Lu M; Dravid P; Zhang Y; Trivedi S; Li A; Harder O; Kc M; Chaiwatpongsakorn S; Zani A; Kenney A; Zeng C; Cai C; Ye C; Liang X; Shimamura M; Liu SL; Mejias A; Ramilo O; Boyaka PN; Qiu J; Martinez-Sobrido L; Yount JS; Peeples ME; Kapoor A; Niewiesk S; Li J Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33688034 [TBL] [Abstract][Full Text] [Related]
19. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Brunet J; Choucha Z; Gransagne M; Tabbal H; Ku M-W; Buchrieser J; Fernandes P; Batalie D; Lopez J; Ma L; Dufour E; Simon E; Hardy D; Petres S; Guinet F; Strick-Marchand H; Monot M; Charneau P; Majlessi L; Duprex WP; Gerke C; Martin A; Escriou N J Virol; 2024 May; 98(5):e0169323. PubMed ID: 38563763 [TBL] [Abstract][Full Text] [Related]
20. Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam. Nguyen HT; Falzarano D; Gerdts V; Liu Q Microbiol Spectr; 2024 Aug; 12(8):e0095924. PubMed ID: 38916311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]